Subscribe

Kassi Filkins

Kassi Filkins is an authr for Ophthalmology Times.

Articles by Kassi Filkins

J&J's XLRP Gene Therapy Bota-Vec Falls Short of Primary End Points

ByKassi Filkins

May 7th 2025

J&J purchased the full rights to bota-vec in a 2023 deal with MeiraGTx

Latest Updated Articles

Trending on CGTlive®

Myrtelle’s Canavan Disease Gene Therapy Effects Significant Decrease in CSF NAA and Increases in Brain Myelin Volume

Regeneron’s Gene Therapy DB-OTO Improves Speech Perception in Children With Otoferlin-Related Hearing Loss

© 2025 MJH Life Sciences^®

All rights reserved.